Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | androgen receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0009 | 0.0009 | 0.034 |
Brugia malayi | Cytochrome P450 family protein | 0.0013 | 0.0268 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0013 | 0.0268 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0009 | 0.0009 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0009 | 0.0009 | 0.034 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0145 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0145 | 1 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0013 | 0.0268 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0013 | 0.0268 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0009 | 0.0009 | 0.034 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0009 | 0.0009 | 0.034 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0009 | 0.0009 | 0.034 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0145 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0145 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0009 | 0.0009 | 0.034 |
Onchocerca volvulus | 0.0009 | 0.0009 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0009 | 0.0009 | 0.034 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0013 | 0.0268 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0013 | 0.0268 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0009 | 0.0009 | 0.034 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0145 | 1 | 1 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0145 | 1 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0009 | 0.0009 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0009 | 0.034 |
Giardia lamblia | Rrm3p helicase | 0.0145 | 1 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0009 | 0.0009 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0145 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 13.7 uM | Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay | ChEMBL. | 23301637 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.